News
Media
Conferences
Publication
Job Board
CME/CE
Partners
Editorial
Resources
Subscribe

Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

Colin Xu, PhD

Articles by Colin Xu, PhD

antidepressants

No, Your Patients Are Not Wrong: Sometimes Antidepressant Side Effects Do Not Get Better

ByColin Xu, PhD,Thomas T. Kim, PhD

April 8th 2025

Contesters of STAR*D discuss the impact and relevance of the study's remission rates.

STAR*D’s Cumulative Remission Rate and Why It Still Matters

ByH. Edmund Pigott, PhD,Thomas T. Kim, PhD,Colin Xu, PhD,Irving Kirsch, PhD,Jay D. Amsterdam, MD

March 6th 2024

Contesters of STAR*D discuss the impact and relevance of the study's remission rates.

Latest Updated Articles

Trending on Psychiatric Times

FDA Approves Caplyta for Adjunctive Treatment of Major Depressive Disorder

The Spiritual Determinants of Health and Mental Health

Caplyta FDA Approval: Benefits for Patients, With Roger McIntyre, MD

Sex Differences and Lifestyle Changes in ADHD

Bridging the Categorical-Dimensional Divide: Exploring the PRiSM Diagnostic Instrument

© 2025 MJH Life Sciences^®

All rights reserved.